Uterine Artery Embolization Long-Term Efficacy Challenged By NICE Panel
This article was originally published in The Gray Sheet
Executive Summary
Evidence on the degree and permanence of uterine artery embolization's efficacy in fibroid treatment is insufficient to support liberal use, according to an advisory panel of the UK's National Institute for Clinical Excellence
You may also be interested in...
InSightec Panel Acquiesces Despite Efficacy, Control Group Concerns
Labeling for InSightec's ExAblate 2000 non-invasive uterine fibroid treatment should describe "mitigations" to minimize the risk of nerve damage during the procedure, FDA advisory panel members recommend
Fibroid Ablation By MRI-Guided Laser: UK’s NICE Declines Endorsement
The UK's National Institute for Clinical Excellence gives magnetic resonance image-guided percutaneous laser ablation for uterine fibroids a mixed review in its recently launched consultation program
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.